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Six multiplex-compatible PCR primers were designed to distinguish Streptococcus pneumoniae serotypes within serogroup 18
from culturable/nonculturable pneumococcal specimens, with no cross-reactivity with other serotypes and respiratory organ-
isms. These primers will aid in the generation of better data on vaccine/nonvaccine serotypes in invasive and carriage pneumo-
coccal surveillance and contribute to future vaccine formulation and impact studies.
Streptococcus pneumoniae is a major cause of infectious diseaseburden worldwide, especially in children (1). It has a highly
diverse polysaccharide capsule that forms the basis of more than
90 different serotypes, whose distribution varies geographically (2,
3). The available pneumococcal conjugate vaccines (PCVs) were
designed to provide immunity against the most prevalent invasive
serotypes worldwide (3, 4). Understanding the geographical dis-
tribution and shifts in prevalence over time of every serotype is
important for optimizing vaccine design and understanding post-
vaccine impact on disease burden.
The current gold standard for serotyping is the Quellung reac-
tion (5). This method is expensive and demands expertise; most
importantly, this method cannot discern serotypes in culture-neg-
ative specimens (6). This limitation has serious implications in
South Asia and Africa, where more than 50% of all meningitis
cases are culture negative due to the common practice of antibi-
otic use prior to seeking care and specimen collection (7, 8). To
overcome these limitations, a PCR-based serotyping scheme was
optimized to determine serotypes from culture-negative speci-
mens (6). However, the available conventional primers cannot
distinguish serotypes within some serogroups, like 18 and 6. Few
quantitative PCR (qPCR) schemes are available (9, 10), but they
lack completeness (can detect 18B/C only) and were not validated
completely due to a lack of culture-negative serogroup-18-posi-
tive clinical specimens. This limits our knowledge about serotype
distribution and vaccine coverage. This is specifically true for
serogroup 18, one of the predominant invasive serogroups
worldwide (7, 11–13), which has four different serotypes 18A,
18B, 18C, and 18F. Only serotype 18C has been included in all
PCVs (14–16). Distribution data of these serotypes are lacking
for all culture-negative cases. Moreover, PCR serotyping di-
rectly from respiratory specimens has received attention re-
cently (17–19). Considering the nasopharynx as the key reser-
voir for transmission (20), the trend of pneumococcus in carriage
is crucial for surveying herd immunity and replacement of vaccine
serotypes after PCV introduction (21, 22). However, the current
PCR serotyping algorithm remains incomplete, as it is unable to
detect serotypes within serogroup 18 (23). Although previous at-
tempts to design serotype-specific primers for serogroup 18 were
unsuccessful due to the high sequence similarity (23, 24), in this
study, we designed new primers to identify and distinguish the
serogroup 18 serotypes.
The pneumococcal capsular genes on the capsule polysaccha-
ride (cps) locus are flanked by the conserved dexB and aliA genes
(25). The first four genes are highly conserved among all sero-
types, but genes in the central part of the locus are more serotype
specific and serve as the basis of differentiation between serotypes
(23). We designed PCR primers to distinguish serogroup 18 sero-
types through manual analysis of a multiple-sequence alignment
of all four published cps locus sequences (26).
For each selected region of the locus, blastn was used to check
its specificity. Once a region was validated to be specific for the
serogroup 18 serotypes (i.e., no significant match was found with
cps loci of other serotypes), primers were designed and checked for
physical properties (melting temperature [Tm], GC% content,
hairpins, and dimers) and multiplex PCR compatibility using
OligoAnalyzer version 3.1 (Integrated DNA Technologies, USA).
Overall, six primers were designed to differentiate between the
serogroup 18 serotypes 18A, 18B/C, and 18F (Fig. 1). Primers to
distinguish 18B and 18C could not be designed using their CPS
sequence due to high (99.99% [21,817/21,819]) sequence identity.
These new primers were evaluated for cross-reactivity with
pneumococcal isolates of other serotypes confirmed through
Quellung reactions. A library of 167 DNA samples from pneumo-
coccal isolates (pneumococcal DNA library), obtained from inva-
sive and carriage sources, was used to validate these primers. This
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library contained 67 different serotypes, and 42 isolates belonged
to serogroup 18 (11 from 18A, 22 from 18C, and nine from 18F).
Further, cross-reaction with other microbial species found in the
same niche as S. pneumoniae was appraised using 79 DNA speci-
mens isolated from nasopharyngeal (NP) swabs containing mul-
tiple species of bacteria (NP-DNA library). Fifty-four of 79 spec-
imens contained S. pneumoniae strains of 25 different serotypes
(one 18A, four 18C, and one 18F), determined by Quellung reac-
tions, along with other bacterial species. Finally, to verify the com-
patibility with DNA from culture-negative clinical specimens, all
new primers were used with 10 culture-negative but serogroup-
18-positive clinical specimens (cerebrospinal fluid, n  9; ascitic
fluid, n  1); those were confirmed using published sequential
multiplex PCR (culture-negative library) (6). Additional informa-
tion on all DNA samples used here is found in File S1 in the
supplemental material.
For 167 pneumococcal isolates, DNA extraction was per-
formed by the boiling method (6); for culture-negative and NP
swab specimens, the QIAamp DNA minikit (Qiagen, Germany)
was used. For multiplex PCR, two 25-l reaction mixtures were
made, (i) one for the pneumococcal DNA library using 5 l of
FIREPol mastermix (Solis BioDyne, Estonia) and 1 l of boiled
DNA lysate and (ii) one for NP swabs and culture-negative library
DNA using 12.5 l of Qiagen multiplex PCR mastermix (Qiagen,
Germany) and 8 l of DNA. Both reaction mixtures contained 0.4
M each primer (Eurofins Genomics, USA). Primers (0.4 M)
targeting the cpsA locus (23) were added to the mixtures as a pos-
itive control. A water-only control was always included. The ther-
mal cycle was 95°C for 15 min, followed by 35 cycles (37 in the case
of the culture-negative library to address the challenge of low
DNA concentration) of 94°C for 40 s, 61°C for 50 s, and 72°C for
60 s, and then at 72°C for 10 min and held at 4°C. The PCR
products were run on a 2% agarose gel.
The multiplex PCR on the pneumococcal isolate library with
167 specimens detected all designated isolates of the serogroup 18
serotypes (see Fig. S2 and File S1 in the supplemental material),
indicating 100% concordance with the Quellung results. No
cross-reaction within and beyond serogroup 18 was observed. All
isolates showed positive results for cpsA except serogroups 25 and
38, which has been described before (27, 28). For the NP swab
library, our multiplex PCR assay was positive only for the pneu-
mococcus-positive NP specimens with specific serotypes 18A/
C/F, with no cross-reaction with nonpneumococcal bacterial
growth (see Fig. S3 and File S1 in the supplemental material).
Most excitingly, our primers amplified DNA in all 10 samples of
the culture-negative library, and they revealed 18C in all nine ce-
rebrospinal fluid (CSF) specimens and 18A in the ascitic fluid
specimen. Figure 2 shows the PCR products for four samples (ad-
ditional data in File S1). All reactions showed amplification for
cpsA, and no dimers with human DNA were seen.
Overall, our results indicate that serotypes within serogroup 18
can be discerned by using the primers described herein, from both
culture-positive and culture-negative, invasive and carriage spec-
imens, without any cross-reactivity to non-serogroup-18 sero-
types, nonpneumococcal respiratory bacteria, or human DNA.
However, they could not be validated with serotype 18B, as none
of our DNA libraries from isolates and carriage specimens con-
tained this serotype, implying that our surveillance of multiple
modalities did not detect any 18B isolates in the last 2 decades (7,
13, 29, 30). Interestingly, serotype 18B has also not been reported
from other countries in this region (31–34). Therefore, we can
presume that all 18B/C-positive cases (by our primers) are 18C
FIG 1 New primers to detect serogroup 18 serotypes (18A, 18B/C, and 18F) and their positions in the cps locus. The schematic of the serogroup 18 serotype cps
locus and organization of the genes with color keys has been adapted from the study by Bentley et al. (26). Genes are represented by boxes and colored according
to the gene key, with gene designations indicated above each box. The cps loci of 18B and 18C are shown together, as their primers (18BC-F and 18BC-R) were
common due to very high sequence identity. The primers used in this study are shown along with their position in the locus (with arrows). Primer sequences are
colored and underlined with their designation shown above/below; the genomic position in the cps locus is presented beside the primer.
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but simultaneously remain vigilant about the isolation of 18B in
this region in the postvaccine era. Recently, an Indian industry,
with support from the Bill & Melinda Gates Foundation (BMGF),
formulated a PCV without 18C (Keith Klugman, BMGF, personal
communication). This is possibly due to the limitation in detect-
ing 18C from culture-negative cases. Therefore, it will be also im-
portant to monitor the trend of 18C, using this primer set, in India
once the new vaccine is introduced.
In Bangladesh, between 2007 and 2014, serogroup 18 ranked
6th (28/442) among all invasive isolates (7). Quellung-based clas-
sification of isolates revealed that 46% of all invasive serogroup 18
strains (13/28) are nonvaccine types 18A and 18F, suggesting the
possibility of their emergence as the dominant serotypes post-
PCV. Moreover, in recent years, 45% of all serogroup 18 menin-
gitis cases were culture negative, similar to results for other sero-
types (7). The lack of isolates from these cases has prevented us
from determining the prevalence of specific serotypes and hence
limited assessments of the effectiveness of PCVs. The new primers
described here will be of paramount significance for comprehen-
sive surveillance on invasive and carriage pneumococcus and PCV
effectiveness studies, specifically in South Asian countries, where
disease burden is high and prior use of antibiotics is common.
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